Company Information

  

Address: 111 WEST LEMON AVE  
City: MONROVIA 
State: CA 
Zip Code: 91016 
Telephone: 626-305-5900 

Description of Business

Primary SIC Code: 2834
(As filed with the SEC)  

We are a clinical­stage biopharmaceutical company focused on discovering and developing engineered monoclonal antibody therapeutics to treat severe and life­threatening diseases with unmet medical needs. We have developed a proprietary XmAb® technology platform that we use to create next­generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer and other conditions. In contrast to conventional approaches to antibody design, which focus on the portion of antibodies that interact with target antigens, we focus on the portion of the antibody that interacts with multiple segments of the immune system and controls antibody structure. This portion, referred to as the Fc domain, is constant and interchangeable among antibodies. Our engineered Fc domains, the XmAb technology, can be readily substituted for natural Fc domains.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
06/2017-0.88NAN/E
03/20170.42NA56.95
12/20160.56NA47.00
09/20160.99NA24.74
06/20160.94NA20.20
03/2016-0.42NAN/E
12/2015-0.45NAN/E
09/2015-0.70NAN/E

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2016 Leverage 2016
Net Inc/Comm Equity0.04Total Liab/Total Assets0.27
Net Inc/Total Assets0.06Total Liab/Inv Cap0.36
Net Inc/Inv Cap0.07Total Liab/Comm Equity0.21
Pretax Inc/Net Sales0.28Interest Coverage Ratio1173.19
Net Inc/Net Sales0.27Curr Debt/EquityNA
Cash Flow/Net Sales1.08LTD/EquityNA
SG&A/NetSales0.15Total Debt/EquityNA
Asset Utilization   Liquidity  
Net Receivables Turnover20.21Quick Ratio1.33
Inventory TurnoverNACurrent Ratio1.33
Inventory Day SalesNANet Rec/Curr Assets0.06
Net Sales/Work Cap2.47Inv/Curr AssetsNA
Net Sales/PP&E28.19  

Income Statement (Millions)

  6/30/2017 3/31/2017 12/31/2016 9/30/2016
Total Revenues(Net Sales) 13.34 4.34 6.44 7.82
Cost of Goods Sold NA NA NA NA
Selling & Admin Exps 4.09 4.81 3.11 3.01
Operating Income -7.67 -15.52 -10.03 -9.26
Interest Exp 0.00 0.00 -0.02 0.00
Pretax Income -6.60 -14.47 -9.22 -8.68
Other Income 1.07 1.06 0.79 0.58
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -6.88 -14.64 -9.07 -8.08

Balance Sheet (Millions)

Assets 6/30/2017 3/31/2017 12/31/2016 9/30/2016
Cash & Short Term Investments 188.49 154.79 130.14 104.31
Receivables - Total 14.88 6.94 8.62 3.09
Inventories - Total NA NA NA NA
Total Current Assets 210.98 166.09 141.65 110.84
Net Property, Plant & Equipment 3.86 3.36 3.11 3.05
Total Assets 416.16 418.30 428.56 322.13
Liabilities        
Accounts Payable 11.82 10.95 10.64 14.27
Debt in Current Liabilities NA NA NA NA
Total Current Liabilities 107.43 106.88 106.29 110.67
Long-Term Debt NA NA NA NA
Total Liabilities 114.80 114.56 114.61 119.71
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock 0.00 0.00 0.00 0.00
Common Stock 0.47 0.47 0.47 0.41
Retained Earnings -259.88 -253.00 -237.96 -228.90
Treasury Stock NA NA NA NA
Total Stockholders' Equity 301.37 303.75 313.95 202.42
Total Liabilities and Stockholders' Equity 416.16 418.30 428.56 322.13

Cash Flow Summary (Millions)

Categories 6/30/2017 3/31/2017 12/31/2016 9/30/2016
Net Cash Provided by Operating Activities -12.79 -10.72 -15.79 134.07
Net Cash Provided by Investing Activities 9.35 8.73 -104.27 -127.67
Net Cash Provided by Financing Activities 1.10 1.03 119.80 0.50

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/20129.52-8.59--
12/201310.17-60.26--
12/20149.52-16.42-0.52
12/201527.76-17.59-0.45
12/201687.5223.620.56
Growth Rates74.11----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional09/30/1713836,73478.28




Report Date : 10/23/2017

Powered By Edgar Online © 2017EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.